Picture of Ceapro logo

CZO Ceapro Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for Ceapro, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.131.862.844.4-4.71
Depreciation
Deferred Taxes
Non-Cash Items0.4180.313-0.2740.220.387
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.2310.443-0.938-1.27-0.052
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities0.8824.453.516.64-3.62
Capital Expenditures-0.338-0.542-0.709-0.341-0.981
Purchase of Fixed Assets
Other Investing Cash Flow Items0.1410.057-0.082-0.048
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-0.197-0.484-0.791-0.389-0.981
Financing Cash Flow Items0-0.01
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.672-0.457-0.308-0.218-0.364
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.0133.512.416.03-4.97